BIRMINGHAM, Ala., March 4, 2020 /PRNewswire/ — Encompass Health Corp. (NYSE: EHC) will host its 2020 investor day today in New York City. Encompass Health President & Chief Executive Officer Mark Tarr will outline the integrated healthcare service provider’s longer term business outlook for the Company.

Executive Vice President and Chief Financial Officer Doug Coltharp, Executive Vice President and President of Inpatient Hospitals Barb Jacobsmeyer, Chief Executive Officer – Home Health & Hospice April Anthony, President – Home Health & Hospice Luke James, and Chief Information Officer Rusty Yeager will join Tarr in providing updates for their respective areas of the business.  

Encompass Health’s last investor day in 2015 focused on strategy changes and the Company’s acquisition of Dallas-based Encompass Home Health & Hospice. Today, the Company will focus on three of the six primary elements of its strategy: sustained growth, advanced technology and quality.

Growth strategy
The Company’s growth strategy is supported by a demographic tailwind of an aging U.S. population that is expected to continue to increase the demand for the types of services the Company provides. The growth strategy is further supported by the increasing preference of seniors to age at home. Encompass Health’s executive team will discuss the new growth targets for the next five years.

Advanced technology
During the presentation, the Company’s executive team will also take a deeper dive into how the Company leverages its clinical expertise, large and proprietary clinical datasets, and proven capabilities in data and predictive analytics to drive clinical and business processes that help the Company provide cost-effective care for payors, providers and patients.

Quality
Additionally, the team will discuss how Encompass Health’s unique combination of facility-based and home-based assets coupled with its investments in technology allow the Company to provide high-quality, cost-effective integrated care. This includes a discussion of how the Company’s integrated care model and use of predictive analytics are reducing readmissions, and thus improving outcomes and reducing the overall cost of care.

Live and recorded webcasts of the investor day presentation and accompanying materials will be available at https://investor.encompasshealth.com.

About Encompass Health 
As a national leader in integrated healthcare services, Encompass Health (NYSE: EHC) offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 134 hospitals, 245 home health locations, and 83 hospice locations in 37 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective, integrated care across the healthcare continuum. Encompass Health is ranked as one of Fortune’s 100 Best Companies to Work For. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter and Facebook.

Forward-Looking Statements
Statements contained in this press release which are not historical facts, such as the Company’s growth strategy and targets, and the growing demand for post-acute care services, are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, the Company’s ability to comply with extensive, complex, and ever-changing federal, state and local regulations and sub-regulatory guidance in both business in general and the healthcare industry specifically; restrictive interpretations of the regulations governing the claims that are reimbursable by Medicare; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving the Company, including any matters related to yet undiscovered issues, if any, in acquired operations; the Company’s ability to attract and retain key management personnel; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of the Company’s or its vendors’ or partners’ information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability as well as unforeseen issues, if any, related to integration of systems of any acquired companies; the Company’s ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures consistent with its growth strategy; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for the Company’s services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels, including as part of national healthcare reform and deficit reduction (such as the Patient-Driven Groupings Model for home health, the new patient assessment measures, which we refer to as "Section GG functional measures," for inpatient rehabilitation, and other payment system reforms) and the Company’s ability to adapt operations to those changes; competitive pressures in the healthcare industry and the Company’s response thereto; the Company’s ability to obtain and retain favorable arrangements with third-party payors; adverse effects resulting from coverage determinations made by Medicare Administrative Contractors regarding its Medicare reimbursement claims and lengthening delays in the Company’s ability to recover improperly denied or recouped claims through the administrative appeals process on a timely basis; the Company’s ability to adapt to changes in the healthcare delivery system, including site-neutral value-based purchasing and involvement in coordinated care initiatives or programs that may arise with its referral sources; a pandemic, epidemic, or other widespread outbreak of an infectious disease or other public health crisis, which could decrease our patient volumes and revenues and lead to staffing and supply shortages and associated cost increases; general conditions in the economy and capital markets, including any disruption, instability, or uncertainty related to armed conflict or an act of terrorism, a governmental impasse over approval of the United States federal budget, an increase to the debt ceiling, an international trade war, a sovereign debt crisis, or a widespread outbreak of an infectious disease;  and other factors which may be identified from time to time in Encompass Health’s SEC filings and other public announcements, including Encompass Health’s Form 10 K for the year ended December 31, 2019.

Media Contact:
Hillary Carnel | 205 970-5912
hillary.carnel@encompasshealth.com

Investor Relations Contact:
Crissy Carlisle | 205 970-5860
crissy.carlisle@encompasshealth.com   

SOURCE Encompass Health Corp.